Abstract
Infliximab, an anti-TNF-α monoclonal antibody has been reported to cause central demyelination. Neuropathy has occasionally been recorded. We describe multifocal motor neuropathy (MMN) in a 47-year-old man associated with infliximab...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Neurology, Neurosurgery & Psychiatry
Paper Title
Journal
Date
